{"id":"https://openalex.org/W2946933889","doi":"https://doi.org/10.1186/s12886-018-1012-y","title":"Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion","display_name":"Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion","publication_year":2019,"publication_date":"2019-01-08","ids":{"openalex":"https://openalex.org/W2946933889","doi":"https://doi.org/10.1186/s12886-018-1012-y","mag":"2946933889","pmid":"https://pubmed.ncbi.nlm.nih.gov/30621653","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6325686"},"language":"en","primary_location":{"id":"doi:10.1186/s12886-018-1012-y","doi":"https://doi.org/10.1186/s12886-018-1012-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-018-1012-y","pdf_url":"https://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/s12886-018-1012-y","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/s12886-018-1012-y","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019902931","display_name":"W. Lloyd Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102874","display_name":"Palmetto Retina Center","ror":"https://ror.org/01bsbwm24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210102874"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"W. Lloyd Clark","raw_affiliation_strings":["Palmetto Retina Center, 124 Sunset Court, West Columbia, SC, 29169, USA. lclark@palmettoretina.com","Palmetto Retina Center, 124 Sunset Court, West Columbia, SC, 29169, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Palmetto Retina Center, 124 Sunset Court, West Columbia, SC, 29169, USA. lclark@palmettoretina.com","institution_ids":["https://openalex.org/I4210102874"]},{"raw_affiliation_string":"Palmetto Retina Center, 124 Sunset Court, West Columbia, SC, 29169, USA","institution_ids":["https://openalex.org/I4210102874"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101493088","display_name":"Mimi Liu","orcid":"https://orcid.org/0000-0002-9594-0972","observed_orcids":["https://orcid.org/0000-0002-9594-0972"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mimi Liu","raw_affiliation_strings":["Colorado Retina Associates, Denver, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Colorado Retina Associates, Denver, CO, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058600706","display_name":"John W. Kitchens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092364","display_name":"Retina Associates of Kentucky","ror":"https://ror.org/00h5rtk23","country_code":"US","type":"other","lineage":["https://openalex.org/I4210092364"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Kitchens","raw_affiliation_strings":["Retina Associates of Kentucky, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina Associates of Kentucky, Lexington, KY, USA","institution_ids":["https://openalex.org/I4210092364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041378794","display_name":"Pin-wen Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pin-wen Wang","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029142727","display_name":"Zdenka Ha\u0161kov\u00e1","orcid":"https://orcid.org/0000-0003-0535-1267","observed_orcids":["https://orcid.org/0000-0003-0535-1267"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zdenka Haskova","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5019902931"],"corresponding_institution_ids":["https://openalex.org/I4210102874"],"apc_list":{"value":2170,"currency":"USD","value_usd":2170},"apc_paid":{"value":2170,"currency":"USD","value_usd":2170},"fwci":2.4165,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.86746239,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"19","issue":"1","first_page":"11","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/retinal-vein-occlusion","display_name":"retinal vein occlusion","score":0.9959999918937683},{"id":"https://openalex.org/keywords/branch-retinal-vein-occlusion","display_name":"branch retinal vein occlusion","score":0.9620000123977661},{"id":"https://openalex.org/keywords/central-retinal-vein-occlusion","display_name":"central retinal vein occlusion","score":0.9990000128746033},{"id":"https://openalex.org/keywords/visual-acuity-gain","display_name":"visual acuity improvement","score":0.8199999928474426},{"id":"https://openalex.org/keywords/baseline-predictors","display_name":"baseline predictors","score":0.703000009059906},{"id":"https://openalex.org/keywords/subretinal-fluid","display_name":"subretinal fluid","score":0.890999972820282},{"id":"https://openalex.org/keywords/macular-volume","display_name":"macular volume","score":0.9819999933242798},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.8629999756813049},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9553642868995667},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.8034801483154297},{"id":"https://openalex.org/C2780699112","wikidata":"https://www.wikidata.org/wiki/Q7246796","display_name":"Pro re nata","level":5,"score":0.7229608297348022},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.6817956566810608},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6546066999435425},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6448934674263},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.4063780903816223},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25246521830558777},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.24036985635757446},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.22246846556663513},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012170","descriptor_name":"Retinal Vein Occlusion","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012170","descriptor_name":"Retinal Vein Occlusion","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1186/s12886-018-1012-y","doi":"https://doi.org/10.1186/s12886-018-1012-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-018-1012-y","pdf_url":"https://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/s12886-018-1012-y","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5303750","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6325686","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6325686","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6325686","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmol","raw_type":"Text"},{"id":"pmid:30621653","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30621653","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC ophthalmology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4805e3bf0f4444c8a7f1c7b1a4efba00","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4805e3bf0f4444c8a7f1c7b1a4efba00","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Ophthalmology, Vol 19, Iss 1, Pp 1-7 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12886-018-1012-y","doi":"https://doi.org/10.1186/s12886-018-1012-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-018-1012-y","pdf_url":"https://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/s12886-018-1012-y","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2946933889.pdf","grobid_xml":"https://content.openalex.org/works/W2946933889.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W104785629","https://openalex.org/W1978704499","https://openalex.org/W1995129325","https://openalex.org/W2052204551","https://openalex.org/W2065624228","https://openalex.org/W2076169604","https://openalex.org/W2101608645","https://openalex.org/W2107443927","https://openalex.org/W2128701654","https://openalex.org/W2143845230","https://openalex.org/W2150950141","https://openalex.org/W2153879487","https://openalex.org/W2158029475","https://openalex.org/W2221370326","https://openalex.org/W2767447900","https://openalex.org/W4237391818"],"related_works":["https://openalex.org/W817224297","https://openalex.org/W2107443927","https://openalex.org/W2989019570","https://openalex.org/W2982106835","https://openalex.org/W2766253888","https://openalex.org/W2964087216","https://openalex.org/W2034477424","https://openalex.org/W2592045738","https://openalex.org/W2144551010","https://openalex.org/W2971167736"],"abstract_inverted_index":{"BACKGROUND:":[0],"To":[1],"identify":[2,87],"baseline":[3,38,88,134,163,181,227],"patient":[4,39,89],"characteristics":[5,40,90],"associated":[6,91,165,184,229],"with":[7,24,63,92,166,185,230,251,255],"early":[8,93,167,186,246],"clinically":[9,94,168,247],"significant":[10,95,169,248],"visual":[11],"acuity":[12],"(VA)":[13],"improvements":[14,96,250],"within":[15,135],"3":[16,136],"months":[17,137],"of":[18,37,59,106,127,138,147,157,177,223,244],"treatment":[19,139],"initiation":[20],"in":[21,29,41,61,71,97,123,171,253],"ranibizumab-treated":[22],"patients":[23,62,254],"retinal":[25],"vein":[26],"occlusion":[27],"(RVO)":[28],"the":[30,42,242],"SHORE":[31,47,72,81],"study.":[32],"METHODS:":[33],"Post":[34],"hoc":[35],"analysis":[36,212],"randomized,":[43],"open-label,":[44],"vision":[45,110,192,233],"examiner-masked":[46],"phase":[48],"4":[49],"study":[50],"that":[51,214],"compared":[52],"monthly":[53],"versus":[54],"pro":[55],"re":[56],"nata":[57],"dosing":[58],"ranibizumab":[60,252],"branch":[64],"and":[65,162,175,204,221],"central":[66],"RVO.":[67,256],"Patients":[68],"who":[69],"enrolled":[70],"fulfilled":[73],"eligibility":[74],"criteria":[75],"per":[76],"protocol":[77],"(N":[78],"=":[79,202,206],"202).":[80],"data":[82],"were":[83,144,182,228],"retrospectively":[84],"analyzed":[85],"to":[86,102,188],"VA,":[98],"defined":[99],"as":[100],"improvement":[101,170,187],"a":[103],"Snellen":[104,155],"equivalent":[105,156,194],"20/40":[107,158,189],"or":[108,120,129,149,159,190],"better":[109,160,191,215],"(\u2265":[111],"69":[112,196],"Early":[113],"Treatment":[114],"Diabetic":[115],"Retinopathy":[116],"Study":[117],"[ETDRS]":[118],"letters)":[119],"an":[121],"increase":[122],"best-corrected":[124],"VA":[125,249],"(BCVA)":[126],"15":[128,148],"more":[130,150,231],"ETDRS":[131,151],"letters":[132,152],"from":[133,153],"initiation.":[140],"Main":[141],"outcome":[142],"measures":[143],"BCVA":[145],"gain":[146],"baseline,":[154],"vision,":[161],"factors":[164],"BCVA.":[172],"RESULTS:":[173],"),":[174],"presence":[176,222],"subretinal":[178,224],"fluid":[179,225],"at":[180,226],"all":[183],"(ETDRS":[193],"\u2265":[195],"letters;":[197],"P":[198,201,205],"<":[199],".0001,":[200],".02,":[203],".03,":[207],"respectively).":[208],"CONCLUSIONS:":[209],"This":[210],"retrospective":[211],"found":[213],"BCVA,":[216],"greater":[217],"total":[218],"macular":[219],"volume,":[220],"rapid":[232],"gains.":[234],"Clinicians":[235],"may":[236],"find":[237],"these":[238],"helpful":[239],"when":[240],"considering":[241],"likelihood":[243],"achieving":[245],"TRIAL":[257],"REGISTRATION:":[258],"ClinicalTrials.gov":[259],"NCT01277302":[260],".":[261]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-06-07T00:00:00"}